![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/519 | |
C07D 473/00 | |||
C07D 487/04 | |||
A61P 29/00 |
(11) | Number of the document | 2175859 |
(13) | Kind of document | T |
(96) | European patent application number | 08781709.4 |
Date of filing the European patent application | 2008-07-11 | |
(97) | Date of publication of the European application | 2010-04-21 |
(45) | Date of publication and mention of the grant of the patent | 2012-03-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2008/069813 |
Date | 2008-07-11 |
(87) | Number | WO 2009/009740 |
Date | 2009-01-15 |
(30) | Number | Date | Country code |
949328 P | 2007-07-12 | US |
(72) |
KRASINSKI, Antoni, US
PUNNA, Sreenivas, US
UNGASHE, Solomon, US
WANG, Qiang, US
ZENG, Yibin, US
|
(73) |
ChemoCentryx, Inc.,
850 Maude Avenue, Mountain View California 94043,
US
|
(54) | FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE TREAMENT OF INFLAMMATION |
FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE TREAMENT OF INFLAMMATION |